ITRM920270A0 - Composizione farmaceutica per il trattamento e la prevenzione delle infiammazioni cutanee e della mucosa orale. - Google Patents

Composizione farmaceutica per il trattamento e la prevenzione delle infiammazioni cutanee e della mucosa orale.

Info

Publication number
ITRM920270A0
ITRM920270A0 IT92RM270A ITRM920270A ITRM920270A0 IT RM920270 A0 ITRM920270 A0 IT RM920270A0 IT 92RM270 A IT92RM270 A IT 92RM270A IT RM920270 A ITRM920270 A IT RM920270A IT RM920270 A0 ITRM920270 A0 IT RM920270A0
Authority
IT
Italy
Prior art keywords
prevention
skin
treatment
pharmaceutical composition
oral mucosa
Prior art date
Application number
IT92RM270A
Other languages
English (en)
Inventor
Aldo Olivieri
Original Assignee
Kemiprogress S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kemiprogress S R L filed Critical Kemiprogress S R L
Priority to ITRM920270A priority Critical patent/IT1254321B/it
Publication of ITRM920270A0 publication Critical patent/ITRM920270A0/it
Priority to EP93830139A priority patent/EP0565495A1/en
Priority to CA002093401A priority patent/CA2093401A1/en
Priority to US08/043,493 priority patent/US5425948A/en
Publication of ITRM920270A1 publication Critical patent/ITRM920270A1/it
Application granted granted Critical
Publication of IT1254321B publication Critical patent/IT1254321B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine

Landscapes

  • Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ITRM920270A 1992-04-10 1992-04-10 Composizione farmaceutica per il trattamento e la prevenzione delle infiammazioni cutanee e della mucosa orale. IT1254321B (it)

Priority Applications (4)

Application Number Priority Date Filing Date Title
ITRM920270A IT1254321B (it) 1992-04-10 1992-04-10 Composizione farmaceutica per il trattamento e la prevenzione delle infiammazioni cutanee e della mucosa orale.
EP93830139A EP0565495A1 (en) 1992-04-10 1993-04-02 Pharmaceutical composition containing glycyrrhetinic acid and phenanthridine alkaloids
CA002093401A CA2093401A1 (en) 1992-04-10 1993-04-05 Pharmaceutical compositions for the treatment and prevention of cutaneous and oral mucous membrane inflammation
US08/043,493 US5425948A (en) 1992-04-10 1993-04-06 Pharmaceutical compositions for the treatment and prevention of cutaneous and oral mucous membrane inflammations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM920270A IT1254321B (it) 1992-04-10 1992-04-10 Composizione farmaceutica per il trattamento e la prevenzione delle infiammazioni cutanee e della mucosa orale.

Publications (3)

Publication Number Publication Date
ITRM920270A0 true ITRM920270A0 (it) 1992-04-10
ITRM920270A1 ITRM920270A1 (it) 1993-10-10
IT1254321B IT1254321B (it) 1995-09-14

Family

ID=11400944

Family Applications (1)

Application Number Title Priority Date Filing Date
ITRM920270A IT1254321B (it) 1992-04-10 1992-04-10 Composizione farmaceutica per il trattamento e la prevenzione delle infiammazioni cutanee e della mucosa orale.

Country Status (4)

Country Link
US (1) US5425948A (it)
EP (1) EP0565495A1 (it)
CA (1) CA2093401A1 (it)
IT (1) IT1254321B (it)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5834002A (en) 1994-05-02 1998-11-10 Josman Laboratories, Inc. Chewing gum containing colloidal bismuth subcitrate
US6426085B1 (en) 1994-05-02 2002-07-30 Josman Laboratories Inc. Use of bismuth-containing compounds in topical oral dosage forms for the treatment of halitosis
US6902738B2 (en) * 1994-05-02 2005-06-07 Josman Laboratories, Inc. Topical oral dosage forms containing bismuth compounds
US6379651B1 (en) 1995-02-07 2002-04-30 Josman Laboratories Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H. pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases
WO1996024341A1 (en) * 1995-02-07 1996-08-15 Narayan Krishnarao Athanikar Concomitant treatment with bismuth and antibacterials
US6372784B1 (en) 1995-02-07 2002-04-16 Josman Laboratories, Inc. Bismuth-containing compounds in topical dosage forms for treatment of corneal and dermal wounds
ZA973751B (en) * 1996-05-03 1998-05-11 Camas Technologies Inc Pesticides comprising benzophenanthridine alkaloids.
DE19654508C1 (de) * 1996-12-18 1998-08-13 Lancaster Group Gmbh Kosmetisches Reinigungs- und Pflegepräparat
KR100230710B1 (ko) * 1997-06-26 1999-11-15 전기영 잇몸질환의 예방 및 치료용 조성물
US5908640A (en) * 1997-07-25 1999-06-01 Embro; William J. Veterinary compositions for treating epidermal irritations
KR100356697B1 (ko) * 1998-03-07 2002-12-18 주식회사 태평양 여드름에효과가있는피부용조성물
US7151082B2 (en) * 1999-02-11 2006-12-19 The Feinstein Institute For Medical Research Antagonists of HMG1 for treating inflammatory conditions
US6303321B1 (en) * 1999-02-11 2001-10-16 North Shore-Long Island Jewish Research Institute Methods for diagnosing sepsis
US7304034B2 (en) * 2001-05-15 2007-12-04 The Feinstein Institute For Medical Research Use of HMGB fragments as anti-inflammatory agents
AUPR726701A0 (en) * 2001-08-24 2001-09-20 HWF Enterprises Pty Ltd Compound for treatment of lesions and tumours
ITMI20020756A1 (it) * 2002-04-09 2003-10-09 Sinclair Pharma S R L Composizioni farmaceutiche topiche per il trattamento delle dermatiti
US7696169B2 (en) * 2003-06-06 2010-04-13 The Feinstein Institute For Medical Research Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents
AU2004272607B2 (en) * 2003-09-11 2008-11-06 Cornerstone Therapeutics Inc. Monoclonal antibodies against HMGB1
WO2007011606A2 (en) * 2005-07-18 2007-01-25 Critical Therapeutics, Inc. USE OF HMGBl ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY SKIN CONDITIONS
US20080311122A1 (en) * 2005-11-28 2008-12-18 Medimmune, Llc Antagonists of Hmgb1 and/or Rage and Methods of Use Thereof
DE102008050036A1 (de) * 2007-10-02 2009-04-30 Kuhs Gmbh Topisch zu applizierende kosmetische oder pharmazeutische Zusammensetzung
ITMI20080038A1 (it) * 2008-01-11 2009-07-12 Indena Spa Formulazioni per il trattamento di mucositi indotte da terapia antitumorale o immunosoppressiva
ITMI20080395A1 (it) * 2008-03-10 2009-09-11 Indena Spa Formulazioni per il trattamento delle verruche e delle placche psoriatiche
US9676696B2 (en) * 2009-01-29 2017-06-13 The Procter & Gamble Company Regulation of mammalian keratinous tissue using skin and/or hair care actives

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2122893B (en) * 1982-06-30 1985-06-26 Biorex Laboratories Ltd Glycyrrhetinic acid compositions
CA1335076C (en) * 1987-04-01 1995-04-04 Hanna R. Kowarski Pharmaceutical composition and method for intranasal administration
US5175000A (en) * 1987-06-30 1992-12-29 Vipont Pharmaceutical, Inc. Free amine benzophenanthridine alkaloid compositions
NZ232572A (en) * 1989-03-13 1991-11-26 Vipont Pharma Oral rinse composition containing a benzophenanthridine alkaloid extract from sanguinaria canadesis
AU6034690A (en) * 1989-07-07 1991-02-06 Atrix Laboratories, Inc. Benzophenanthridine alkaloids for topical acne treatment
JP2998287B2 (ja) * 1991-03-13 2000-01-11 千寿製薬株式会社 グリチルレチン酸誘導体

Also Published As

Publication number Publication date
IT1254321B (it) 1995-09-14
ITRM920270A1 (it) 1993-10-10
EP0565495A1 (en) 1993-10-13
CA2093401A1 (en) 1993-10-11
US5425948A (en) 1995-06-20

Similar Documents

Publication Publication Date Title
ITRM920270A0 (it) Composizione farmaceutica per il trattamento e la prevenzione delle infiammazioni cutanee e della mucosa orale.
NO933239D0 (no) Bioeroderbar innretning for administering av aktive ingredienser
DE69326539T2 (de) Zytotoxische arzneimittel therapie
FI963883A (fi) Farmaseuttisia valmisteita ja lääkeaineita endoteelin toimintahäiriön ehkäisemiseksi ja hoitamiseksi
EE04493B1 (et) Tsüklopenteeni derivaadid, neid sisaldav farmatseutiline kompositsioon ning ühendite kasutamine ravimina inimestel esinevate motiliini retseptoriga seotud häirete raviks
IT8720771A0 (it) Composizioni farmaceutiche per la prevenzione e terapia della calcolosi delle vie biliari e della dispepsia biliare.
DE3875866D1 (de) Sulfonamidolphenyl-derivate und diese enthaltende therapeutische und vorbeugend wirkende mittel gegen arrhythmie.
IT9019112A1 (it) Composizioni farmaceutiche e forme di dosaggio per la somministrazione orale di calcitonina
NO20002526D0 (no) Mellomprodukt med høyt legemiddelinnhold og orale doseringspreparater med modifisert frigivelse samt fremgangsmÕter for fremstilling derav
IT1291340B1 (it) Formulazioni farmaceutiche contenenti colostro e uso del colostro per il trattamento di affezioni del cavo orale
ITMI910456A0 (it) Composizione farmaceutica per il trattamento della cataratta
ITRM960827A0 (it) Medicamento per il trattamento terapeutico della maculopatia legata all'eta', della maculopatia non legata all'eta' e per la profilassi
IT1277117B1 (it) Composizioni farmaceutiche per il trattamento delle ipercolesterolemie
IT1282952B1 (it) Formulazioni farmaceutiche gastroresistenti contenenti colostro e uso del colostro per il trattamento della costipazione
ITPD920141A1 (it) Formulazioni farmaceutiche per la somministraziane orale di calcitonina
ITBO910490A0 (it) -composizione farmaceutica per il trattamento delle adiposita' localizzata e della cellulite.
ITMI931174A0 (it) Composizioni farmaceutiche per la cura della talassemia
IT1269340B (it) Composizione farmaceutica per il trattamento delle disfunzioni erettili
IT1224897B (it) Composizione farmaceutica per il trattamento delle affezioni parodontali
IT1282951B1 (it) Formulazioni farmaceutiche gastroresistenti contenenti colostro e uso del colostro per il trattamento dell'insonnia
ITMI932494A1 (it) Composizioni farmaceutiche per uso orale per il trattamento delle manifestazioni ulcerose gastro-duodenali ed esofagee
ITGE940025A0 (it) Preparazione farmaceutica ad uso topico per la cura della psoriasi e di altre dermatosi.
ITMI911930A1 (it) Composizioni farmaceutiche di stereoisomeri di ossiracetam e loro impiego terapeutico.
ITPE920005A0 (it) Composizioni farmaceutiche nel trattamento delle alopecie primitive o secondarie e della psoriasi.
IT8646805A0 (it) Sussidio per la prevenzione e la cura delle piaghe da decubito